These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18272839)

  • 1. ARPKD and ADPKD: first cousins or more distant relatives?
    Kaimori JY; Germino GG
    J Am Soc Nephrol; 2008 Mar; 19(3):416-8. PubMed ID: 18272839
    [No Abstract]   [Full Text] [Related]  

  • 2. Another cystic mystery solved.
    Coffman TM
    Nat Genet; 2002 Mar; 30(3):247-8. PubMed ID: 11919556
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
    Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
    J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding ion transport mechanisms in polycystic kidney disease.
    Sudarikova AV; Vasileva VY; Sultanova RF; Ilatovskaya DV
    Clin Sci (Lond); 2021 Nov; 135(21):2521-2540. PubMed ID: 34751394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of autosomal recessive polycystic kidney disease (ARPKD).
    Al-Bhalal L; Akhtar M
    Adv Anat Pathol; 2008 Jan; 15(1):54-8. PubMed ID: 18156813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of ADPKD.
    Harris PC
    Contrib Nephrol; 1995; 115():8-15. PubMed ID: 8585923
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).
    Fischer DC; Jacoby U; Pape L; Ward CJ; Kuwertz-Broeking E; Renken C; Nizze H; Querfeld U; Rudolph B; Mueller-Wiefel DE; Bergmann C; Haffner D
    Nephrol Dial Transplant; 2009 Jun; 24(6):1819-27. PubMed ID: 19176689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies: a key to understanding pathogenesis in PKD.
    Harris PC
    Nephrol News Issues; 2006 Dec; 20(13):20-2. PubMed ID: 17168054
    [No Abstract]   [Full Text] [Related]  

  • 12. Autosomal recessive polycystic kidney disease (ARPKD).
    Zerres K; Rudnik-Schöneborn S; Senderek J; Eggermann T; Bergmann C
    J Nephrol; 2003; 16(3):453-8. PubMed ID: 12832752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From gene to disease; PKHD1 and recessive polycystic kidney disease].
    Peters DJ; Losekoot M; de Die-Smulders CE; Stevens-Baldewijns M; Breuning MH
    Ned Tijdschr Geneeskd; 2005 Feb; 149(9):463-6. PubMed ID: 15771341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.
    Israeli S; Amsler K; Zheleznova N; Wilson PD
    Am J Physiol Cell Physiol; 2010 Apr; 298(4):C831-46. PubMed ID: 19923420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the molecular pathophysiology of polycystic kidney disease.
    Murcia NS; Sweeney WE; Avner ED
    Kidney Int; 1999 Apr; 55(4):1187-97. PubMed ID: 10200981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment.
    Haumann S; Müller RU; Liebau MC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal recessive polycystic kidney disease (ARPKD): new insights from the identification of the ARPKD gene, PKHD1.
    Guay-Woodford LM
    Pediatr Res; 2002 Dec; 52(6):830-1. PubMed ID: 12438655
    [No Abstract]   [Full Text] [Related]  

  • 20. A role for microRNA in cystic liver and kidney diseases.
    Chu AS; Friedman JR
    J Clin Invest; 2008 Nov; 118(11):3585-7. PubMed ID: 18949060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.